✦ LIBER ✦

Pyramidal tract imaging in multiple-system atrophy

✍ Scribed by Nicole Limberg; Susanne Jeavons; Thomas Robertson; Richard Boyle

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 97 KB
Volume: 20
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20610

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A new radiological finding of T2 FLAIR hyperintensities in the pyramidal tracts is described in a patient clinically thought to have idiopathic Parkinson's disease but histologically proven to have multiple‐system atrophy. © 2005 Movement Disorder Society

📜 SIMILAR VOLUMES

Pyramidal tract degeneration in multiple

Pyramidal tract degeneration in multiple system atrophy: The relevance of magnetization transfer imaging

✍ Antonio José da Rocha; Antonio Carlos Martins Maia Jr.; Carlos Jorge da Silva; F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

## Abstract The clinical features of multiple system atrophy (MSA) include four domains: autonomic failure/urinary dysfunction, Parkinsonism, cerebellar ataxia, and corticospinal tract dysfunction. Although the diagnosis of definite MSA requires pathological confirmation, magnetic resonance imaging

Survival in multiple system atrophy

✍ Anette Schrag; Gregor K. Wenning; Niall Quinn; Yoav Ben-Shlomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eighty‐five of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twenty‐four patients came to autopsy, which showed MSA

Therapeutic strategies in multiple syste

Therapeutic strategies in multiple system atrophy

✍ Gregor K. Wenning; Felix Geser; Werner Poewe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

This review provides an update on therapeutic principles and their implications for practical management in multiple system atrophy (MSA), a sporadic neurodegenerative disorder characterized clinically by various combinations of dysautonomia, Parkinsonism, or cerebellar ataxia, often associated with

Facial myokymia in multiple system atrop

Facial myokymia in multiple system atrophy

✍ Dr. S. B. Blunt; N. M. Khalil; G. D. Perkin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

## Abstract Two patients are described with clinical and neuroimaging features consistent with a diagnosis of multiple system atrophy (MSA). The patients are unusual in that facial myokymia became apparent clinically at some stage in their illness. In each patient, the nature and severity of the in

Diffusion-weighted imaging in multiple s

Diffusion-weighted imaging in multiple system atrophy: A comparison between clinical subtypes

✍ Maria Teresa Pellecchia; Paolo Barone; Carmine Mollica; Elena Salvatore; Marta I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

## Abstract Multiple system atrophy can be classified into two main types, a Parkinsonian (MSA‐P) and a cerebellar (MSA‐C) variant based on clinical presentation. We obtained diffusion‐weighted magnetic resonance imaging (DWI) in 9 MSA‐P and 12 MSA‐C patients and 11 controls, and correlated DWI cha

Stridor and death in multiple system atr

Stridor and death in multiple system atrophy

✍ Michael H. Silber; Samantha Levine 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

Patients with multiple system atrophy (MSA) have a mean survival of 8 to 10 years. Nocturnal stridor has been considered a poor prognostic feature. We analyzed demographic, clinical, and polysomnographic data and obtained follow-up information from 42 patients with MSA (30 with follow-up data) seen